Neutrophil-to-lymphocyte ratio as a prognostic factor for patients with metastatic or recurrent breast cancer treated using capecitabine: a retrospective study

Peer Review reports

Original Submission
19 Mar 2021	Submitted	Original manuscript
31 Oct 2021	Reviewed	Reviewer Report
27 Nov 2021	Reviewed	Reviewer Report
3 Dec 2021	Author responded	Author comments - Tatsunori Shimoi
Resubmission - Version 2
3 Dec 2021	Submitted	Manuscript version 2
Publishing
14 Dec 2021	Editorially accepted
14 Jan 2022	Article published	10.1186/s12885-021-09112-9

Back to article page